DK0879056T3 - Modulation af Th1/Th2-cytokinekspression med ribavirin i aktiverede T-lymfocytter - Google Patents
Modulation af Th1/Th2-cytokinekspression med ribavirin i aktiverede T-lymfocytterInfo
- Publication number
- DK0879056T3 DK0879056T3 DK97904765T DK97904765T DK0879056T3 DK 0879056 T3 DK0879056 T3 DK 0879056T3 DK 97904765 T DK97904765 T DK 97904765T DK 97904765 T DK97904765 T DK 97904765T DK 0879056 T3 DK0879056 T3 DK 0879056T3
- Authority
- DK
- Denmark
- Prior art keywords
- activated
- ribavirin3
- ribavirin
- lymphocytes
- modulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/052—Imidazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/056—Triazole or tetrazole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/590,449 US5767097A (en) | 1996-01-23 | 1996-01-23 | Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes |
| US3609497P | 1997-01-17 | 1997-01-17 | |
| PCT/US1997/000600 WO1997026883A1 (en) | 1996-01-23 | 1997-01-21 | Modulation of th1/th2 cytokine expression by ribavirin® and ribavirin® analogs in activated t-lymphocytes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0879056T3 true DK0879056T3 (da) | 2002-08-19 |
Family
ID=26712784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97904765T DK0879056T3 (da) | 1996-01-23 | 1997-01-21 | Modulation af Th1/Th2-cytokinekspression med ribavirin i aktiverede T-lymfocytter |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0879056B1 (ru) |
| KR (1) | KR100298158B1 (ru) |
| CN (1) | CN1190198C (ru) |
| AT (1) | ATE216886T1 (ru) |
| BR (1) | BR9707154A (ru) |
| CA (1) | CA2246162C (ru) |
| CZ (1) | CZ293584B6 (ru) |
| DE (1) | DE69712316T2 (ru) |
| DK (1) | DK0879056T3 (ru) |
| ES (1) | ES2172764T3 (ru) |
| HU (1) | HU220105B (ru) |
| IL (1) | IL125088A0 (ru) |
| NO (1) | NO983372L (ru) |
| NZ (1) | NZ330784A (ru) |
| PL (1) | PL187439B1 (ru) |
| PT (1) | PT879056E (ru) |
| RU (1) | RU2186569C2 (ru) |
| SI (1) | SI9720013A (ru) |
| SK (1) | SK283342B6 (ru) |
| UA (1) | UA46815C2 (ru) |
| WO (1) | WO1997026883A1 (ru) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1302474A1 (en) * | 1996-10-16 | 2003-04-16 | Ribapharm, Inc. | Monocyclic L-nucleosides, analogs and uses thereof |
| KR100518903B1 (ko) | 1996-10-25 | 2005-10-06 | 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 | Ｔｈ2 매개 질병 및 관련 질병의 치료용 면역 반응 조절 화합물 |
| KR20020023939A (ko) * | 1999-01-29 | 2002-03-29 | 와트 씨 데이빗, 해리 에이 루스제 | 리바비린에 의해 면역 반응을 조절하는 방법 |
| US6455508B1 (en) * | 2000-02-15 | 2002-09-24 | Kanda S. Ramasamy | Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides |
| US7638496B2 (en) | 2000-02-15 | 2009-12-29 | Valeant Pharmaceuticals North America | Nucleoside analogs with carboxamidine modified monocyclic base |
| US6680059B2 (en) | 2000-08-29 | 2004-01-20 | Tripep Ab | Vaccines containing ribavirin and methods of use thereof |
| RU2286172C2 (ru) | 2000-08-17 | 2006-10-27 | Трипеп Аб | Вакцины, содержащие рибавирин, и способы их использования |
| WO2002014362A2 (en) * | 2000-08-17 | 2002-02-21 | Tripep Ab | A hepatitis c virus non-structural ns3/4a fusion gene |
| US7022830B2 (en) | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| ATE447967T1 (de) | 2001-09-14 | 2009-11-15 | Cytos Biotechnology Ag | Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung |
| MXPA05010419A (es) * | 2003-03-28 | 2006-05-31 | Pharmasset Inc | Compuestos para el tratamiento de infecciones por flaviviridae. |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| EP1973608A1 (en) | 2005-12-14 | 2008-10-01 | Cytos Biotechnology AG | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| RU2498813C2 (ru) * | 2006-03-09 | 2013-11-20 | Ом Фарма | Иммуномодуляторные соединения и лечение заболеваний, связанных со сверхпродукцией воспалительных цитокинов |
| DK2032592T3 (da) | 2006-06-12 | 2013-09-02 | Cytos Biotechnology Ag | Fremgangsmåder til pakning af oligonukleotider til virus-lignende partikler af rna-bakteriofager |
| EP2185195A2 (en) | 2007-08-16 | 2010-05-19 | Tripep Ab | Immunogen platform |
| US9073960B2 (en) | 2011-12-22 | 2015-07-07 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| EP2861611B1 (en) | 2012-05-25 | 2016-07-13 | Janssen Sciences Ireland UC | Uracyl spirooxetane nucleosides |
| WO2014100505A1 (en) | 2012-12-21 | 2014-06-26 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| TW201524990A (zh) | 2013-10-11 | 2015-07-01 | Alios Biopharma Inc | 經取代之核苷、核苷酸及其類似物 |
| AU2015259053B2 (en) | 2014-05-16 | 2020-12-24 | Amgen Inc. | Assay for detecting Th1 and Th2 cell populations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06507404A (ja) * | 1991-05-01 | 1994-08-25 | ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 感染性の呼吸性疾患の治療方法 |
-
1997
- 1997-01-21 UA UA98073815A patent/UA46815C2/uk unknown
- 1997-01-21 HU HU9900681A patent/HU220105B/hu not_active IP Right Cessation
- 1997-01-21 PT PT97904765T patent/PT879056E/pt unknown
- 1997-01-21 PL PL97328003A patent/PL187439B1/pl not_active IP Right Cessation
- 1997-01-21 DK DK97904765T patent/DK0879056T3/da active
- 1997-01-21 DE DE69712316T patent/DE69712316T2/de not_active Revoked
- 1997-01-21 KR KR1019980705645A patent/KR100298158B1/ko not_active IP Right Cessation
- 1997-01-21 AT AT97904765T patent/ATE216886T1/de not_active IP Right Cessation
- 1997-01-21 ES ES97904765T patent/ES2172764T3/es not_active Expired - Lifetime
- 1997-01-21 CA CA002246162A patent/CA2246162C/en not_active Expired - Lifetime
- 1997-01-21 SI SI9720013A patent/SI9720013A/sl not_active IP Right Cessation
- 1997-01-21 CN CNB971917760A patent/CN1190198C/zh not_active Expired - Fee Related
- 1997-01-21 WO PCT/US1997/000600 patent/WO1997026883A1/en active IP Right Grant
- 1997-01-21 BR BR9707154A patent/BR9707154A/pt not_active Application Discontinuation
- 1997-01-21 RU RU98115594/14A patent/RU2186569C2/ru active
- 1997-01-21 SK SK1004-98A patent/SK283342B6/sk not_active IP Right Cessation
- 1997-01-21 CZ CZ19982329A patent/CZ293584B6/cs not_active IP Right Cessation
- 1997-01-21 IL IL12508897A patent/IL125088A0/xx unknown
- 1997-01-21 EP EP97904765A patent/EP0879056B1/en not_active Revoked
- 1997-01-21 NZ NZ330784A patent/NZ330784A/xx unknown
-
1998
- 1998-07-22 NO NO983372A patent/NO983372L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO983372L (no) | 1998-09-21 |
| CZ293584B6 (cs) | 2004-06-16 |
| RU2186569C2 (ru) | 2002-08-10 |
| HUP9900681A2 (hu) | 1999-07-28 |
| CA2246162A1 (en) | 1997-07-31 |
| WO1997026883A1 (en) | 1997-07-31 |
| KR19990081930A (ko) | 1999-11-15 |
| KR100298158B1 (ko) | 2001-09-06 |
| NZ330784A (en) | 1999-02-25 |
| PL328003A1 (en) | 1999-01-04 |
| SK283342B6 (sk) | 2003-06-03 |
| ATE216886T1 (de) | 2002-05-15 |
| AU1747897A (en) | 1997-08-20 |
| NO983372D0 (no) | 1998-07-22 |
| CZ232998A3 (cs) | 1999-04-14 |
| HUP9900681A3 (en) | 1999-12-28 |
| SI9720013A (sl) | 1999-06-30 |
| HU220105B (hu) | 2001-10-28 |
| PT879056E (pt) | 2002-10-31 |
| UA46815C2 (uk) | 2002-06-17 |
| CA2246162C (en) | 2000-04-04 |
| PL187439B1 (pl) | 2004-07-30 |
| CN1209747A (zh) | 1999-03-03 |
| BR9707154A (pt) | 1999-05-25 |
| AU700642B2 (en) | 1999-01-14 |
| DE69712316T2 (de) | 2003-01-02 |
| EP0879056A1 (en) | 1998-11-25 |
| CN1190198C (zh) | 2005-02-23 |
| EP0879056A4 (en) | 1999-01-13 |
| SK100498A3 (en) | 2001-03-12 |
| DE69712316D1 (en) | 2002-06-06 |
| IL125088A0 (en) | 1999-01-26 |
| ES2172764T3 (es) | 2002-10-01 |
| EP0879056B1 (en) | 2002-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0879056T3 (da) | Modulation af Th1/Th2-cytokinekspression med ribavirin i aktiverede T-lymfocytter | |
| EP0219076A3 (en) | Sustained release composition | |
| ATE49126T1 (de) | Mittel zur transdermalen applikation von arzneistoffen. | |
| DE59007178D1 (de) | Verwendung alkylierter Polyethylenimine als gallensäureadsorbierende Arzneimittel sowie pharmazeutische Präparate. | |
| DE3677897D1 (de) | Menschliche komplementfaktoren und ihre therapeutische verwendung. | |
| DE3682457D1 (de) | Geraet zur verabreichung von medikamenten an patienten. | |
| ES2056854T3 (es) | Tiadiazinonas. | |
| ATE157251T1 (de) | Verwendung von inositoltriphosphat zur behandlung von entzündungen | |
| BR9814957A (pt) | Tratamento de doenças imune mediadas por célula auxiliar "t" tipo 2 com antagonistas retinóides | |
| ES2197500T3 (es) | Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico. | |
| DE59407457D1 (de) | Blockierung der anlagerung von keimen an menschliche zellen | |
| ES2151607T3 (es) | Factor 12 de crecimiento y de diferenciacion. | |
| KR900007424A (ko) | 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물 | |
| DK0951553T3 (da) | Adenovirus-E4-proteiner til induktion af celledød | |
| EP1240899A3 (en) | Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections | |
| DE3750151D1 (de) | Verwendung von aktivierten T-Lymphozyten zur Vorbereitung einer pharmazeutischen Zusammensetzung zur Behandlung von AIDS. | |
| Rumore et al. | A review of mechanism of action of aspirin and its potential as an immunomodulating agent | |
| ATE84058T1 (de) | Gel-zusammensetzung. | |
| EP1174141A3 (en) | Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes | |
| ATE87207T1 (de) | Azapropazon zur praevention von post-ischaemischem gewebeschaden. | |
| DK222988A (da) | Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer | |
| ES2026966T3 (es) | Procedimiento para la obtencion de 4-metil-4-fenil-1-penta--nales y su empleo como perfumantes. | |
| ATE51517T1 (de) | Rollstuhl und anwendungsweise. | |
| YU61302A (sh) | Analozi nukleozida sa modifikovanom karboksamidinskom bicikličnom bazom | |
| ATE54941T1 (de) | Cystein verminderte muteine von biologisch aktiven menschlichen tnf-proteinen. |